课题基金 / 基金详情

A study of cell survival mechanisms for apoptosis-resistant oral squamous cell carcinoma cell line

A study of cell survival mechanisms for apoptosis-resistant oral squamous cell carcinoma cell line
抗凋亡口腔鳞状细胞癌细胞系的细胞存活机制研究
批准号:
15592137
负责人:
SAKAI Takayuki
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

SAKAI Takayuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Lactoferrin (Lfn) show multi biological function including host defense against not only bacteria and virus but also malignant neoplasm. We previously reported that Lfn peptides (Lfn-p), produced by acid-pepsin hydrolysis of Lfn, induced apaptosis through JNK activation in human oral squamous cell carcinoma cell lines, SAS. (Sakai T et al., J Pharmacol Sci 98,2005) In contrast, we found that Lf-p-induced phospholipase D (PLD) activation in other squamous cell carcinoma cell line, HSC-4, survived in Lf-p-treatment. In the present study, we examined the effect of knockdown of endogenous PLD by small interference RNA (siRNA) on survival signaling activated with Lfn-p in HSC-4 cells. Both PLD1 and 2 were expressed in the cells. The reduction of expression level of PLD1, not PLD2, by siRNA transfection suppressed Lfn-p-induced PLD activity. Lfn-p-induced Akt phosphorylation, well-known survival signaling were also suppressed with PLD activity. Furthermore, JNK phosphorylaiton accompanied by Lfn-p-induced apoptosis in HSC-4 cells was increased in PLD1 knockdown cells. These results suggested that PLD1 was involved in cell survival through PI3K/Akt /JNK pathway in HSC-4 cells.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Possible involvement of phosphatidiylcholine-specific phospholipase C in prostaglandin F2α-stimulated proliferation in osteoblast-like MC3T3-E1 cells.
磷脂酰胆碱特异性磷脂酶 C 可能参与前列腺素 F2α 刺激的成骨细胞样 MC3T3-E1 细胞增殖。
DOI: --
发表时间: 2004
期刊: J. Bone Mineral Metabolism 22・3
影响因子: --
作者: [Sakai T, Kawaguchi M., Sakai T, 坂井隆之, Sakai T]
通讯作者: Sakai T
悪性腫瘍の化学療法:頭頸部領域での現状とポストゲノム時代のオーダーメイド治療の可能性
恶性肿瘤化疗:头颈部肿瘤的现状及后基因组时代个体化治疗的可能性
DOI: --
发表时间: 2005
期刊: 歯科学報 105・1
影响因子: --
作者: [Sakai T, Kawaguchi M., Sakai T, 坂井隆之]
通讯作者: 坂井隆之
ラクトフェリン酵素分解産物の口腔扁平上皮癌細胞へのアポトーシス誘導と抵抗性.
口腔鳞状细胞癌细胞中乳铁蛋白酶降解产物的凋亡诱导和抵抗。
DOI: --
发表时间: 2005
期刊: ミルクサイエンス 53・4
影响因子: --
作者: [Koh, Shibutani, Akio, Uda, 卯田昭夫, Sakai T, 坂井隆之]
通讯作者: 坂井隆之
Chemotherapy of malignant tumor : Trends in head and Neack malignancy and the potential of post-human genome project to individual medicine.
恶性肿瘤化疗:头部和颈部恶性肿瘤的趋势以及后人类基因组计划对个体医学的潜力。
DOI: --
发表时间: 2005
期刊: The Shika Gakuho 105(1)
影响因子: --
作者: [Sakai T, Kawaguchi M.]
通讯作者: Kawaguchi M.
9
    EFFECT OF THE ORGANS AND TISSUES IN THE SPLANCHNIC AREA ON THE BIODEGRADATION OF HALOTHANE
    • 批准号:
      62570712
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.47万
    • 财政年份:
      1987
    • 负责人:
      SAKAI Takayuki
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位:
    双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
    • 批准号:
      81670594
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2016
    • 负责人:
      陈昊
    • 依托单位:
    Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
    • 批准号:
      81470791
    • 项目类别:
      面上项目
    • 资助金额:
      73.0万元
    • 批准年份:
      2014
    • 负责人:
      董家鸿
    • 依托单位: